Manufacturer record
Fresenius Kabi Oncology Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Fresenius Kabi Oncology Ltd (Himachal Pradesh) was declared Not of Standard Quality in February 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 887YY042, Leucovorin Calcium Injection I.P. (exp Nov 2019). CDSCO, Sub Zone, Baddi (state lab) found it not of standard quality: Description and Particulate Matter. Listed in the February 2019 alert.
Records by type
1 record linked to Fresenius Kabi Oncology Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Leucovorin Calcium Injection I.P. | Batch 887YY042Mfg Dec 2017 · Exp Nov 2019 | Description and Particulate MatterDescription | CDSCO, Sub Zone, BaddiState lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.